Cancer patients' lived experiences on their pathway to CAR-T cell trial participation
To gain a deeper understanding of journeys before, during, and after CAR-T therapy for hematological malignancy, we gathered insights and feedback from patients, caregivers and healthcare professionals (HCPs).